Nanjing Well Pharmaceutical Group Co. Ltd. Class ASSE: 603351

Announcement on Receiving Letter of 2nd-round Review and Inquiry on Public Issuance of Convertible Corporate Bonds from SSE

· Issued by Nanjing Well Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Receiving Letter of 2nd-round Review and Inquiry on Public Issuance of Convertible Corporate Bonds from SSE

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis